Cochrane distances itself from controversial views on psychiatric drugsBMJ 2015; 351 doi: https://doi.org/10.1136/bmj.h5073 (Published 23 September 2015) Cite this as: BMJ 2015;351:h5073
- Jacqui Wise
The Cochrane research organisation has stated unequivocally that it does not share the views of Peter Gøtzsche, the director of the Nordic Cochrane Centre, on the benefits and harms of psychiatric drugs.1
The research organisation said that it had been forced to issue a statement after Gøtzsche wrote an article in the Daily Mail saying that psychiatric drugs were Britain’s third biggest killer after heart disease and cancer and that doctors were handing them out like sweets.2 In the article Gøtzsche said that as an investigator for the Cochrane Collaboration his role was to look forensically at the evidence for effects of treatments.
He quoted his new book, Deadly Psychiatry and Organised Denial, in which he said that the …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial